RECRUITING

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.

Official Title

Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation

Quick Facts

Study Start:2025-01-10
Study Completion:2029-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06472089

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult caregivers (≥18 years) who is a relative or friend whom the patient identified as living with them or having in-person contact with them at least twice a week.
  2. * Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer.
  3. * Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter.
  1. * Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT.
  2. * Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.

Contacts and Locations

Study Contact

Areej El-Jawahri, MD
CONTACT
617-721-4000
ael-jawahri@mgb.org
Jamie Jacobs, PhD
CONTACT
617-724-4000
jjacobs@mgh.harvard.edu

Principal Investigator

Areej El-Jawahri, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Jamie Jacobs, PhD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

University of Alabama at Brimingham
Birmingham, Alabama, 35294
United States
Moffitt Cancer Center
Tampa, Florida, 33612
United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Areej El-Jawahri, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital
  • Jamie Jacobs, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-10
Study Completion Date2029-02

Study Record Updates

Study Start Date2025-01-10
Study Completion Date2029-02

Terms related to this study

Keywords Provided by Researchers

  • Neoplasms by Site
  • Hematologic Diseases
  • Neoplasms
  • Hematologic Neoplasms

Additional Relevant MeSH Terms

  • Bone Marrow Transplant Complications
  • Hematologic Malignancy